Institute of Medical Molecular Genetics, University of Zurich, Schwerzenbach, Switzerland.
Eur J Hum Genet. 2013 Mar;21(3):352-6. doi: 10.1038/ejhg.2012.137. Epub 2012 Jun 27.
Wagner syndrome (WS) is an autosomal dominant vitreoretinopathy affecting various ocular features and is caused by mutations in the canonical splice sites of the VCAN gene, which encodes the large chondroitin sulfate proteoglycan, versican. We report the identification of novel splice acceptor and donor-site mutations (c.4004-1G>C and c.9265+2T>A) in two large WS families from France and the United Kingdom. To characterize their pathogenic mechanisms we performed qRT-PCR experiments on RNA from patient-derived tissues (venous blood and skin fibroblasts). We also analyzed RNA from the original Swiss family reported by Wagner (who has the previously reported c.9265+1G>A mutation). All three mutations resulted in a quantitative increase of transcript variants lacking exons 7 and/or 8. However, the magnitude of the increase varied between tissues and mutations. We discuss altered balance of VCAN splice variants in combination with reduction in glycosaminoglycan protein modifications as possible pathogenic mechanisms.
瓦格纳综合征(WS)是一种常染色体显性遗传性玻璃体视网膜病变,可影响多种眼部特征,由 VCANGENE 基因的典型剪接位点突变引起,该基因编码大型软骨素硫酸蛋白聚糖,即 versican。我们报道了在来自法国和英国的两个大型 WS 家族中鉴定出新型剪接受体和供体位点突变(c.4004-1G>C 和 c.9265+2T>A)。为了研究其致病机制,我们对源自患者组织(静脉血和皮肤成纤维细胞)的 RNA 进行了 qRT-PCR 实验。我们还分析了 Wagner 报道的原始瑞士家族的 RNA(该家族具有先前报道的 c.9265+1G>A 突变)。所有三种突变均导致缺乏外显子 7 和/或 8 的转录变体的定量增加。然而,增加的幅度在组织和突变之间有所不同。我们讨论了 VCAN 剪接变体平衡的改变与糖胺聚糖蛋白修饰的减少相结合作为可能的致病机制。